2 TSX Stocks Dipped Over 15% in July: Should You Buy or Sell?

The most common mistake investors do is to sell the dip and buy the rally. Don’t make this mistake with these two stocks. 

| More on:

The July month saw some correction as the rising cases of Delta variant, and the phase-out of the Canada Recovery Benefit (CRB) slowed recovery. Even the recovering earnings couldn’t help push the stock market. The TSX Composite Index dipped 4.62% in July as the Toronto stock exchange is skewed toward energy stocks, which were down. However, tech stocks performed well. 

Two TSX stocks that dipped in July 

What caught my attention were two shares, Cineplex (TSX:CSX) and BlackBerry (TSX:BB)(NYSE:BB). They surged beautifully since the start of the year over the hopes of recovery. But their recovery is now facing a correction, making investors anxious as they see the red lines on their portfolio. 

If you hold these stocks in your portfolio, don’t panic. Continue holding them and read further because it is important to know why these shares are falling. Making buy and sell decisions just by looking at the share price is not the right way forward. This can lead to losses that will take you a long time to recover. 

Cineplex stock 

I will start with the theatre chain Cineplex. The stock surged 82% this year in the hopes of recovery. There was news everywhere that Cineplex is opening its theatres after 15 months. Then, its U.S. counterpart AMC got caught in the Reddit short squeeze and rose to unprecedented levels. This raised hopes that maybe Cineplex could become a potential meme stock, but that didn’t happen.  

Then came the Delta variant, putting a stop to the reopening of Cineplex. Investors feared that moviegoers might once again resume binge-watching on the over-the-top platforms, pulled Cineplex stock down 23.3% in July. If you purchased the stock at around $16, a loss of over 20% might seem heavy. Should you book the loss or hold the stock? 

Fear is the biggest enemy of an investor. Nothing has changed for Cineplex. The cinema chain knew the reopening won’t be smooth; there would be waves and temporary closures. It even feared the worst that OTT viewers won’t return to the big screen. But theatre has a different user experience, and Cineplex is leveraging that strength to increase the footfall. 

It will report its second-quarter earnings on August 12. I am hoping to see some revenue growth outlook. It will take a while for the company to return to profit, but that was not what guided the stock price rally.

It was the revenue growth from the reopening, and it will come back. That is when the stock will soar again, and you will feel happy that you overcame your fears and held on to the stock. 

BlackBerry 

BlackBerry’s share dipped 16% in July. This meme stock surged 75% even after excluding the inflated price from the short squeeze. But the stock dipped below the $13 mark in July as Redditors cashed out on meme stocks. They only held the stock to sell at an inflated price to hedge funds that have shorted the stock. This whole strategy has nothing to do with BlackBerry’s management, earnings, or business prospects. 

Such gamma squeeze momentum is difficult to time. Hence, you must enter such stocks at the right price point. I have been screaming from the start of the year BlackBerry is a long-term stock. But do not buy the share above the $12 price. Because any price above $12 is the squeeze effect. Like rubber, the share will bounce back to its fundamental price. 

This is the right time to buy the share, and if you already own it hold on to it. BlackBerry will introduce its IVY automotive data platform in October and then launch it in February 2022.

It also has an order backlog for the QNX platform. Electric cars and the 5G rollout might act as the technology infrastructure catalyst it needs to grow in the long term. Don’t let the 16% dip get into your head. It is the time to buy and not sell. 

Fool’s way 

The above two shares are those where buy the dip sell the rally can earn you good money. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Puja Tayal has no position in any of the stocks mentioned. The Motley Fool recommends BlackBerry and CINEPLEX INC.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »